ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gordon L. Larsen
James A. Alexander
William Stanford
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsen, G. L.
Right arrow Articles by Stanford, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsen, G. L.
Right arrow Articles by Stanford, W.

Ann Thorac Surg 1977;23:323-326
© 1977 The Society of Thoracic Surgeons

Articles

Thromboembolic Phenomena in Patients with Prosthetic Aortic Valves Who Did Not Receive Anticoagulants

Gordon L. Larsen, M.D., James A. Alexander, MAJ, USAF, MC, William Stanford, COL, USAF, MC*

Cardiothoracic Surgery Service, Department of Surgery, Wilford Hall USAF Medical Center, Lackland AFB, TX.

Accepted for publication August 11, 1976.

* Address reprint requests to Dr. Stanford, Chief, Cardiothoracic Surgery (SGHST), Wilford Hall USAF Medical Center, Lackland AFB, TX 78236.

Seventy-two patients with Starr-Edwards aortic prostheses of the 2300 series were followed for 1 to 73 months (average, 22 months) without receiving anticoagulants. Nine patients had clinical evidence of an embolic episode (12.5%). One of these patients died, and 5 were left with a significant residual neurological deficit. Two other patients had hemiparesis but recovered fully. Only 1 episode could be considered minor. The reported lower incidence of thromboembolism in patients receiving this prosthesis with adequate anticoagulation has now led us to reverse our previous position and recommend anticoagulation for patients receiving Starr-Edwards aortic prostheses.




This article has been cited by other articles:


Home page
 Med Decis MakingHome page
A. S. Dunn, J. Wisnivesky, W. Ho, C. Moore, T. McGinn, and H. S. Sacks
Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
Med Decis Making, July 1, 2005; 25(4): 387 - 397.
[Abstract] [PDF]

Home page
 ChestHome page
D. Hering, C. Piper, R. Bergemann, C. Hillenbach, M. Dahm, C. Huth, and D. Horstkotte
Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement: Results of the German Experience With Low-Intensity Anticoagulation Study
Chest, January 1, 2005; 127(1): 53 - 59.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. H. Eckman, J. R. Beshansky, I. Durand-Zaleski, H. J. Levine, and S. G. Pauker
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves: Does Low Risk Mean High Cost?
JAMA, March 16, 1990; 263(11): 1513 - 1521.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thrombotic and Bleeding Complications of Prosthetic Heart Valves
Ann. Thorac. Surg., October 1, 1987; 44(4): 430 - 445.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thromboembolic Complications of Current Cardiac Valvular Prostheses
Ann. Thorac. Surg., July 1, 1982; 34(1): 96 - 106.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1977 by The Society of Thoracic Surgeons.